Commonwealth Banks Financial Results Summary for the Quarter

May 09, 2023

Commonwealth Bank of Australia (ASX: CBA) shares financial results summary for the quarter which shows:

  • The unaudited statutory NPAT for the quarter was AU$ 2.6 billion, and the unaudited cash NPAT was AU$ 2.6 billion, up 1% on the 1H23 quarterly average (up 3% on a day-weighted basis) and up 10% on the prior comparative quarter.
  • The expenses were also flat on a headline basis, but they were down 1% when excluding remediation. The operating performance remained consistent with the 1H23 quarterly average, showing a 2% increase on a day-weighted basis, while it demonstrated an 18% improvement compared to the prior comparative quarter.
  • The loan impairment expense was AU$223 million, with collective and individual provisions slightly higher.
  • Despite financial conditions tightening, the portfolio credit quality remained sound, and credit provisions increased slightly to strengthen the balance sheet position further.
  • The balance sheet maintained its strength with a CET1 (Level 2) ratio of 12.1% under APRA's updated capital framework, resulting in a surplus of capital amounting to AU$ 8.7 billion beyond the minimum regulatory requirement.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com